A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder

MLA

Christian R. Marshall, et al. “A Microcosting and Cost–consequence Analysis of Clinical Genomic Testing Strategies in Autism Spectrum Disorder.” Genetics in Medicine, vol. 19, Nov. 2017, pp. 1268–75. EBSCOhost, https://doi.org/10.1038/gim.2017.47.

APA

Christian R. Marshall, Edwin J. Young, Wilson W L Sung, Richard M. Zur, Dimitri J. Stavropoulos, Kate Tsiplova, Daniele Merico, Wendy J. Ungar, Sergio L. Pereira, & Stephen W. Scherer. (2017). A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Genetics in Medicine, 19, 1268–1275. https://doi.org/10.1038/gim.2017.47

Chicago

Christian R. Marshall, Edwin J. Young, Wilson W L Sung, Richard M. Zur, Dimitri J. Stavropoulos, Kate Tsiplova, Daniele Merico, Wendy J. Ungar, Sergio L. Pereira, and Stephen W. Scherer. 2017. “A Microcosting and Cost–consequence Analysis of Clinical Genomic Testing Strategies in Autism Spectrum Disorder.” Genetics in Medicine 19 (November): 1268–75. doi:10.1038/gim.2017.47.